Concepedia
Statistics
Publications
69
Citations
3.9K
H-Index
34
Active since
2005
Affiliations
Incyte (United States)(Current)
Experimental Station
Bristol-Myers Squibb (United States)
Swamy Yeleswaram is an author at Incyte (United States) specializing in pharmacology, medicine, and pharmacy.
Publications per year
2005–2024
Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
Jordan S. Fridman, Peggy Scherle, Robert J. Collins et al. · The Journal of Immunology · 2010 · 463 citations · Full text
Medicine, Immunology, Pharmacology +17
The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers
Jack Shi, Xuejun Chen, Fiona Lee et al. · The Journal of Clinical Pharmacology · 2014 · 229 citations
Medicine, Pharmacokinetics, Pharmacology +13
Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344
Carrie Brodmerkel, Reid Huber, Maryanne Covington et al. · The Journal of Immunology · 2005 · 188 citations
Life Sciences, Immunology, Pharmacology +17
Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis
Naresh Punwani, Peggy Scherle, Robert Flores et al. · Journal of the American Academy of Dermatology · 2012 · 182 citations
Medicine, Dermatology, Pharmacology +9
The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers
Jack Shi, Xuejun Chen, Ryan McGee et al. · The Journal of Clinical Pharmacology · 2011 · 167 citations
Pharmacy, Pharmacokinetics, Pharmacology +15
1–5 of 69